A program to screen women for cervical cancer using AI has been launched in Ho Chi Minh City in Vietnam.
Community organisation Ho Chi Minh City Public Health Association (HPHA) partnered with listed Australian company TruScreen and its local distributor Gorton Health Services to run the community-based program, which aims to screen 260,000 women in the city over five years.
The partnership...
Women's health company Teal Health announced it garnered an additional $10 million in seed funding to support the launch of the Teal Wand, an at-home, self-collect cervical cancer screening device, which is currently under review by the FDA.
The additional capital will bring Teal Health's funding to $23 million.
Emerson Collective and Forerunner led the round with participation from Serena...
China Maternal and Child Health Care Association and Wuhan University Landing AI Cytology Diagnostic Centre recently launched a cervical cancer screening AI cloud diagnostic platform. The platform can be accessed worldwide as of April 1, 2019 and women, especially those from countries along Belt and Road Initiative, will be able to benefit from a high-quality, low-cost cervical cancer screening...
Age played a major role in Chilean women’s attitudes toward text message reminders for Papanicolaou (Pap) testing, according to a small study published by JMIR mHealth and uHealth.
The study set out to investigate the barriers preventing Chilean women from getting tested for cervical cancer by setting up focus groups to talk to patients. Twenty-seven women between the ages of 25 and 64 who did...
In a recent JMIR study, a team of researchers in Minnesota explored the potential of mobile health to reach people who sometimes fall through the cracks of the healthcare system. They found that a text message intervention could help Korean American women, a group that has one of the highest cervical cancer mortality rates in the United States, seek preventative screenings (Pap tests).
"A variety...